Novartis: Clinical Trials & Research Profile

Biopharma Industry (Basel, CH / East Hanover, NJ) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Basel, CH / East Hanover, NJ)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies179 active (80 recruiting now)
Total Tracked Studies (2018 to 2026)492 (212 with California sites)
Completed vs Early-Stopped Studies194 completed / 119 stopped (24.2% stop rate)
Median Closed Enrollment119 participants
FDA Drugs@FDA Original Approvals224 all-time (29 from 2018 to 2026)
Physical Hospital Site Disclosure22.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Novartis across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk